(secondQuint)Linezolid for Treatment of Nontuberculous Mycobacterial Diseases.

 This will be an open label clinical study of oral linezolid combination with another oral antimycobacterial drug as the maintenance treatment of nontuberculous mycobacterial diseases in adult.

 The eligible patients will be treated and monitored for the efficacy and safety every 6 weeks until 6 months then every 3 months for a total duration of 18 months.

.

 Linezolid for Treatment of Nontuberculous Mycobacterial Diseases@highlight

A prospective open study to determine the efficacy and tolerability of oral linezolid 600mg.

/day for the treatment of 50 patients with nontuberculous mycobacterial diseases will be conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.

